Floatz logo

33 assets in Metastatic Carcinoma In The Bone

Therapeutic assets addressing Metastatic Carcinoma In The Bone, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Denosumab
Metastatic Carcinoma In The Bone
Kelly Fitzgerald, MDP4BBB (79)
Zoledronate
Metastatic Carcinoma In The Bone
Kelly Fitzgerald, MDP4BBB (79)
Ibandronate
Metastatic Carcinoma In The Bone
Kelly Fitzgerald, MDP4BBB (76)
Radium Ra-223
Metastatic Carcinoma In The Bone
University of California, San FranciscoP3BB (69)
Technetium Tc-99M Cation, Unspecified
Metastatic Carcinoma In The Bone
University of California, San FranciscoP3BB (67)
Cabozantinib
Metastatic Carcinoma In The Bone
National Cancer Institute (NCI)P3BB (66)
Carboplatin
Metastatic Carcinoma In The Bone
Actuate Therapeutics Inc.P2BB (65)
Ketorolac
Metastatic Carcinoma In The Bone
St. Louis UniversityP3B (60)
Marble Dust
Metastatic Carcinoma In The Bone
Albert Einstein College of MedicineP2B (60)
Nepenthe
Metastatic Carcinoma In The Bone
St. Louis UniversityP3B (60)
Nivolumab
Metastatic Carcinoma In The Bone
National Cancer Institute (NCI)P3B (60)
Oxycodone
Metastatic Carcinoma In The Bone
St. Louis UniversityP3B (60)
Oxycodone Hydrochloride, Hydrocodone-
Metastatic Carcinoma In The Bone
St. Louis UniversityP3B (60)
Ipilimumab
Metastatic Carcinoma In The Bone
National Cancer Institute (NCI)P3B (59)
Durvalumab
Metastatic Carcinoma In The Bone
Institut Cancerologie de l'OuestP2B (57)
Adriamycin
Metastatic Carcinoma In The Bone
Children's National Research InstituteP2CCC (53)
Irinotecan
Metastatic Carcinoma In The Bone
Actuate Therapeutics Inc.P2CCC (53)
jmt103
Metastatic Carcinoma In The Bone
Shanghai JMT-Bio Inc.P1CCC (53)
Lomustine
Metastatic Carcinoma In The Bone
Actuate Therapeutics Inc.P2CCC (53)
Tislelizumab
Metastatic Carcinoma In The Bone
Zhejiang Cancer HospitalP2CCC (53)
Zanzalintinib
Metastatic Carcinoma In The Bone
Kelly Fitzgerald, MDP2CCC (53)
Elraglusib
Metastatic Carcinoma In The Bone
Actuate Therapeutics Inc.P2CCC (50)
Trastuzumab
Metastatic Carcinoma In The Bone
City of Hope Medical CenterP1CC (46)
1,4,7,10-TETRAAZACYCLODODECANE-1,4,7,10-TETRAMETHYLENEPHOSPHONIC ACID
Metastatic Carcinoma In The Bone
QSAM Therapeutics, Inc.P1CC (43)
Copanlisib
Metastatic Carcinoma In The Bone
M.D. Anderson Cancer CenterP1CC (43)
Elimusertib
Metastatic Carcinoma In The Bone
M.D. Anderson Cancer CenterP1CC (43)
Kb-Gdt-01
Metastatic Carcinoma In The Bone
Kiromic BioPharma Inc.P1CC (43)
Mozobil
Metastatic Carcinoma In The Bone
Albert Einstein College of MedicineP1CC (43)
Nivestim
Metastatic Carcinoma In The Bone
Albert Einstein College of MedicineP1CC (43)
SM-153-DOTMP
Metastatic Carcinoma In The Bone
Albert Einstein College of MedicineP1CC (43)
Trastuzumab Emtansine
Metastatic Carcinoma In The Bone
City of Hope Medical CenterN/AD (30)
Almb-0168
Metastatic Carcinoma In The Bone
AlaMab Therapeutics (Shanghai) Inc.P2NR ()
Zetamet™
Metastatic Carcinoma In The Bone
Zetagen Therapeutics, IncP2NR ()